Schedule 13D ownership disclosure

CONCERT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 206022105

Event date: 2014-02-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,208,920
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-010741
Form type
SC 13D
Filer
CONCERT PHARMACEUTICALS, INC.
CIK
CIK 1367920
Filed
Feb 17, 2015
Reporting period
Feb 18, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub